These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 21778901)

  • 1. Diffuse uremic tumoral calcinosis in a patient on long-term hemodialysis.
    Akasbi N; Houssaini TS; Rabhi S; Lahlou M; Boukhrissa A; Tahiri L; El Maaroufi C; Berrady R; Harzy T; Bono W
    J Clin Rheumatol; 2011 Aug; 17(5):272-4. PubMed ID: 21778901
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia.
    Cozzolino M; Staniforth ME; Liapis H; Finch J; Burke SK; Dusso AS; Slatopolsky E
    Kidney Int; 2003 Nov; 64(5):1653-61. PubMed ID: 14531797
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of sevelamer and calcium-based phosphate binders on coronary artery calcification and accumulation of circulating advanced glycation end products in hemodialysis patients.
    Kakuta T; Tanaka R; Hyodo T; Suzuki H; Kanai G; Nagaoka M; Takahashi H; Hirawa N; Oogushi Y; Miyata T; Kobayashi H; Fukagawa M; Saito A
    Am J Kidney Dis; 2011 Mar; 57(3):422-31. PubMed ID: 21239096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cervical tumoral calcinosis with secondary hyperparathyroidism in a chronic hemodialysis patient.
    Sunder S; Verma H; Venkataramanan K
    Hemodial Int; 2013 Jul; 17(3):458-62. PubMed ID: 23072397
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumoral calcinosis, calciphylaxis, hyperparathyroidism and tuberculosis in a dialysis patient.
    Kammoun K; Jarraya F; Hmida MB; Khebir A; Kharrat M; Boudawara T; Mnif J; Hachicha J
    Saudi J Kidney Dis Transpl; 2011 Mar; 22(2):306-10. PubMed ID: 21422631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of non-calcium-based phosphate binders on vascular calcifications in patients on hemodialysis: clinical experience and hypotheses].
    Bolasco P
    G Ital Nefrol; 2011; 28(4):357. PubMed ID: 21809303
    [No Abstract]   [Full Text] [Related]  

  • 7. [Tumorous calcinosis in hemodialysis: anatomo-clinical study apropos of 3 cases].
    Ben Taarit C; el Younsi F; Turki S; Mestiri M; Zlitni M; Ben Maïz H
    Nephrologie; 2001; 22(7):349-52. PubMed ID: 11817212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uremic tumoral calcinosis in hemodialysis patients: clinicopathological findings and identification of calcific deposits.
    Hamada J; Tamai K; Ono W; Saotome K
    J Rheumatol; 2006 Jan; 33(1):119-26. PubMed ID: 16395759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of sevelamer on the progression of vascular calcification in patients on chronic haemodialysis.
    Takei T; Otsubo S; Uchida K; Matsugami K; Mimuro T; Kabaya T; Akiba T; Nitta K
    Nephron Clin Pract; 2008; 108(4):c278-83. PubMed ID: 18434749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uremic tumoral calcinosis in patients receiving longterm hemodialysis therapy.
    Cofan F; García S; Combalia A; Campistol JM; Oppenheimer F; Ramón R
    J Rheumatol; 1999 Feb; 26(2):379-85. PubMed ID: 9972973
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resolution of massive uremic tumoral calcinosis with daily nocturnal home hemodialysis.
    Kim SJ; Goldstein M; Szabo T; Pierratos A
    Am J Kidney Dis; 2003 Mar; 41(3):E12. PubMed ID: 12613005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blockage of the renin-angiotensin system attenuates mortality but not vascular calcification in uremic rats: sevelamer carbonate prevents vascular calcification.
    Tokumoto M; Mizobuchi M; Finch JL; Nakamura H; Martin DR; Slatopolsky E
    Am J Nephrol; 2009; 29(6):582-91. PubMed ID: 19145073
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Posttransplant regression of uremic tumoral calcinosis].
    de Alarcón RM; Palomares M; Marfil A; Asensio C
    Nefrologia; 2007; 27(3):378-81. PubMed ID: 17725459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Switching from calcium carbonate to sevelamer hydrochloride has suppressive effects on the progression of aortic calcification in hemodialysis patients: assessment using plain chest X-ray films.
    Izumi M; Morita S; Nishian Y; Miyamoto T; Kasumoto H; Oue M; Hori K; Kitamura R; Yamamoto S; Nakanishi T
    Ren Fail; 2008; 30(10):952-8. PubMed ID: 19016145
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. No good evidence to promote a general use of sevelamer.
    Nguyen QV; Descombes E
    Kidney Int; 2008 Jan; 73(2):238-9, author reply 239. PubMed ID: 18165813
    [No Abstract]   [Full Text] [Related]  

  • 17. Massive, painful tumoral calcinosis in a long-term hemodialysis patient.
    Carvalho M; de Menezes IA; Riella MC
    Hemodial Int; 2011 Oct; 15(4):577-80. PubMed ID: 22093521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients.
    Block GA; Raggi P; Bellasi A; Kooienga L; Spiegel DM
    Kidney Int; 2007 Mar; 71(5):438-41. PubMed ID: 17200680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis.
    Block GA; Spiegel DM; Ehrlich J; Mehta R; Lindbergh J; Dreisbach A; Raggi P
    Kidney Int; 2005 Oct; 68(4):1815-24. PubMed ID: 16164659
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular calcification and QT interval in incident hemodialysis patients.
    Di Iorio BR; Cucciniello E; Bellizzi V
    J Nephrol; 2009; 22(6):694-8. PubMed ID: 19967647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.